Epstein Becker Green (EBG) supported a private equity sponsor in its sale of a pharmaceutical company.
EBG conducted pre-sell diligence and aided the company in addressing health regulatory matters involving the Food and Drug Administration, the Drug Enforcement Agency and state-controlled substances laws, and the Consumer Product Safety Commission. EBG also supported the client in responding to buy-side inquiries and negotiating regulatory terms.
Results may vary depending on your particular facts and legal circumstances.